evaluating clinical pathways for ovarian cancer treatment and maintenance therapy
Published 5 years ago • 2.3K plays • Length 29:51Download video MP4
Download video MP3
Similar videos
-
39:25
navigating rapid change in ovarian cancer: parp inhibitors in clinical pathways
-
1:04:52
practice-changing updates in ovarian cancer: implications for pathways construction
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
50:21
parp inhibitor therapy for ovarian cancer: practical prescribing and medication management
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
48:35
utilizing clinical pathways for remission maintenance in ovarian cancer
-
33:15
ovarian cancer: standards of care and new opportunities - dr. robert coleman
-
46:00
advanced breast cancer: challenges in pathways development
-
24:56
gynecologic cancer education: parp inhibitor therapy
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
26:02
updates in ovarian cancer: frontline maintenance
-
56:15
updates in ovarian cancer research, with dr rowan miller
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
1:41:03
ovarian cancer symposium 2021: session 2 immunotherapy and targeted therapy
-
0:31
ovarian cancer patient has extraordinary response to clinical trial treatment
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
0:38
did you know ovarian cancer affects more than just ovaries? | aoi.
-
55:39
latest updates in low grade serous ovarian cancer treatment and research
-
59:02
parp inhibitors as first-line maintenance therapy in ovarian cancer